Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1741 - 1750 of 44979 results found

In Silico Evaluation of NO-Sartans against SARS-CoV-2

Date
Wednesday, March 06, 2024 - 4:00 AM
Description
CONCLUSION: Based on our in silico studies, CLC-1280 (a Valsartan dinitrate) has the potential to be considered as an inhibitor of the SARS-CoV-2 virus. However, further in vitro and in vivo evaluations are necessary for the drug development process.